Title : Targeting NRAS-Mutant Cancers with the Selective STK19 Kinase Inhibitor Chelidonine.

Pub. Date : 2020 Jul 1

PMID : 32156748






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Targeting NRAS-Mutant Cancers with the Selective STK19 Kinase Inhibitor Chelidonine. chelidonine serine/threonine kinase 19 Mus musculus
2 RESULTS: Chelidonine was identified as a potent and selective inhibitor of STK19 kinase activity. chelidonine serine/threonine kinase 19 Mus musculus